SULFONAMIDE DERIVATIVE AND AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT

PROBLEM TO BE SOLVED: To provide a new sulfonamide derivative useful as an active component for prostaglandin E2 antagonistic or agonistic agent. SOLUTION: The objective compound is expressed by formula I [a group of formula II is a 5 to 7-membered heterocyclic group having a 5-7C carbon ring, O, S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OUCHIDA SHUICHI, NAGAO HISAKI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OUCHIDA SHUICHI
NAGAO HISAKI
description PROBLEM TO BE SOLVED: To provide a new sulfonamide derivative useful as an active component for prostaglandin E2 antagonistic or agonistic agent. SOLUTION: The objective compound is expressed by formula I [a group of formula II is a 5 to 7-membered heterocyclic group having a 5-7C carbon ring, O, S and N; Z1 is COR1 (R1 is OH or the like) or the like; Z2 is a 1-8C alkyl, a 2-8C alkenyl or the like; Z3 is single bond or a 1-4C alkylene; Z4 is SO2; Z5 is a 1-8C alkyl, phenyl or the like; R2 is CONR8 (R8 is H or a 1-4C alkyl), NR8CO or the like; R3 is a 1-6C alkyl, a halogen or the like; R4 is a 1-8C alkyl or the like; (n) is 1-4], e.g. 5-[5-chloro-2-(phenylsulfonylamino)phenoxy] pentaonic acid. The compound of formula I wherein Z1 is e.g. COOH can be produced by the hydrolysis of an ester compound of formula III [Z1b is COR1b (R1b is a 1-4C alkoxy or the like); R3b is R3; R4b is R4; Z5b is Z5, provided that Z5b is COOH or OH protected with an eliminable protecting group when R5 is COOH, OH or the like].
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2000007646A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2000007646A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2000007646A3</originalsourceid><addsrcrecordid>eNrjZPALDvVx8_dz9PV0cVVwcQ3yDHMM8QxzVXD0c1FwdHf1C1Fw9vcLcfT08_RzVwjxQFUTrODoDGY5-_sG-PsBVfMwsKYl5hSn8kJpbgYlN9cQZw_d1IL8-NTigsTk1LzUknivACMDEDA3MzFzNCZKEQB0eS7o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SULFONAMIDE DERIVATIVE AND AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT</title><source>esp@cenet</source><creator>OUCHIDA SHUICHI ; NAGAO HISAKI</creator><creatorcontrib>OUCHIDA SHUICHI ; NAGAO HISAKI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a new sulfonamide derivative useful as an active component for prostaglandin E2 antagonistic or agonistic agent. SOLUTION: The objective compound is expressed by formula I [a group of formula II is a 5 to 7-membered heterocyclic group having a 5-7C carbon ring, O, S and N; Z1 is COR1 (R1 is OH or the like) or the like; Z2 is a 1-8C alkyl, a 2-8C alkenyl or the like; Z3 is single bond or a 1-4C alkylene; Z4 is SO2; Z5 is a 1-8C alkyl, phenyl or the like; R2 is CONR8 (R8 is H or a 1-4C alkyl), NR8CO or the like; R3 is a 1-6C alkyl, a halogen or the like; R4 is a 1-8C alkyl or the like; (n) is 1-4], e.g. 5-[5-chloro-2-(phenylsulfonylamino)phenoxy] pentaonic acid. The compound of formula I wherein Z1 is e.g. COOH can be produced by the hydrolysis of an ester compound of formula III [Z1b is COR1b (R1b is a 1-4C alkoxy or the like); R3b is R3; R4b is R4; Z5b is Z5, provided that Z5b is COOH or OH protected with an eliminable protecting group when R5 is COOH, OH or the like].</description><edition>7</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000111&amp;DB=EPODOC&amp;CC=JP&amp;NR=2000007646A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000111&amp;DB=EPODOC&amp;CC=JP&amp;NR=2000007646A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OUCHIDA SHUICHI</creatorcontrib><creatorcontrib>NAGAO HISAKI</creatorcontrib><title>SULFONAMIDE DERIVATIVE AND AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT</title><description>PROBLEM TO BE SOLVED: To provide a new sulfonamide derivative useful as an active component for prostaglandin E2 antagonistic or agonistic agent. SOLUTION: The objective compound is expressed by formula I [a group of formula II is a 5 to 7-membered heterocyclic group having a 5-7C carbon ring, O, S and N; Z1 is COR1 (R1 is OH or the like) or the like; Z2 is a 1-8C alkyl, a 2-8C alkenyl or the like; Z3 is single bond or a 1-4C alkylene; Z4 is SO2; Z5 is a 1-8C alkyl, phenyl or the like; R2 is CONR8 (R8 is H or a 1-4C alkyl), NR8CO or the like; R3 is a 1-6C alkyl, a halogen or the like; R4 is a 1-8C alkyl or the like; (n) is 1-4], e.g. 5-[5-chloro-2-(phenylsulfonylamino)phenoxy] pentaonic acid. The compound of formula I wherein Z1 is e.g. COOH can be produced by the hydrolysis of an ester compound of formula III [Z1b is COR1b (R1b is a 1-4C alkoxy or the like); R3b is R3; R4b is R4; Z5b is Z5, provided that Z5b is COOH or OH protected with an eliminable protecting group when R5 is COOH, OH or the like].</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPALDvVx8_dz9PV0cVVwcQ3yDHMM8QxzVXD0c1FwdHf1C1Fw9vcLcfT08_RzVwjxQFUTrODoDGY5-_sG-PsBVfMwsKYl5hSn8kJpbgYlN9cQZw_d1IL8-NTigsTk1LzUknivACMDEDA3MzFzNCZKEQB0eS7o</recordid><startdate>20000111</startdate><enddate>20000111</enddate><creator>OUCHIDA SHUICHI</creator><creator>NAGAO HISAKI</creator><scope>EVB</scope></search><sort><creationdate>20000111</creationdate><title>SULFONAMIDE DERIVATIVE AND AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT</title><author>OUCHIDA SHUICHI ; NAGAO HISAKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2000007646A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2000</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><toplevel>online_resources</toplevel><creatorcontrib>OUCHIDA SHUICHI</creatorcontrib><creatorcontrib>NAGAO HISAKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OUCHIDA SHUICHI</au><au>NAGAO HISAKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SULFONAMIDE DERIVATIVE AND AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT</title><date>2000-01-11</date><risdate>2000</risdate><abstract>PROBLEM TO BE SOLVED: To provide a new sulfonamide derivative useful as an active component for prostaglandin E2 antagonistic or agonistic agent. SOLUTION: The objective compound is expressed by formula I [a group of formula II is a 5 to 7-membered heterocyclic group having a 5-7C carbon ring, O, S and N; Z1 is COR1 (R1 is OH or the like) or the like; Z2 is a 1-8C alkyl, a 2-8C alkenyl or the like; Z3 is single bond or a 1-4C alkylene; Z4 is SO2; Z5 is a 1-8C alkyl, phenyl or the like; R2 is CONR8 (R8 is H or a 1-4C alkyl), NR8CO or the like; R3 is a 1-6C alkyl, a halogen or the like; R4 is a 1-8C alkyl or the like; (n) is 1-4], e.g. 5-[5-chloro-2-(phenylsulfonylamino)phenoxy] pentaonic acid. The compound of formula I wherein Z1 is e.g. COOH can be produced by the hydrolysis of an ester compound of formula III [Z1b is COR1b (R1b is a 1-4C alkoxy or the like); R3b is R3; R4b is R4; Z5b is Z5, provided that Z5b is COOH or OH protected with an eliminable protecting group when R5 is COOH, OH or the like].</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2000007646A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
title SULFONAMIDE DERIVATIVE AND AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A19%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OUCHIDA%20SHUICHI&rft.date=2000-01-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2000007646A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true